Menstrual Migraine Clinical Trial
Official title:
Measure of Intracranial Pressure Variations During Migraine Attacks
An increase in intracranial pressure (ICP) during migraine attacks is possible and could contribute to pain initiation and maintenance. From now on, it was not possible to measure ICP in a non-invasive way. The development of a new tool allows non-invasive self-measures of ICP variations. Thus, it is possible for the first time to look for such ICP variations during migraine attacks and to conclude if this mechanism is implied in the pathophysiology of migraine.
Womens presenting with regular menstrual migraine treated with triptans will be included in the study. Self-measure of ICP will be performed outside and during menstrual migraine attacks. The potential variations will be compared to the measures done on matched healthy women outside and during menses. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04600388 -
Efficacy and Safety of Nerivio for the Acute Treatment of Menstrual Migraine
|
||
| Not yet recruiting |
NCT03702114 -
Detecting Auricular Points in MMG by a Novel APD ( APD-MMG )
|
||
| Not yet recruiting |
NCT02592681 -
Comparison of the Prophylactic Effect Between Acupuncture and Acupressure on Menstrual Migraine
|
N/A | |
| Completed |
NCT01329562 -
CGRP, Estrogen, Cortisol, VIP, α-Amylase, PGE2, PGI2 and ß-Endorphin Levels in Menstrual Migraine Before and After Treximet
|
Phase 4 | |
| Recruiting |
NCT06173661 -
Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45
|
Phase 4 | |
| Completed |
NCT01578941 -
An Investigation of the Safety and Utility of Treximet in the Treatment of Menstrual Migraine
|
Phase 4 | |
| Completed |
NCT04102995 -
A Study Investigating the Efficacy and Safety of Sepranolone in Women With Menstrual Migraine
|
Phase 2 | |
| Terminated |
NCT01395264 -
Saccadometry in Primary Headache Syndromes
|
N/A | |
| Terminated |
NCT01114711 -
Frovatriptan and Menstrual Migraine
|